Altered Nutrition - Nursing Case Study

Pathophysiology

• Primary mechanism: Malabsorption - This occurs when the small intestine fails to absorb nutrients efficiently due to damage or disease (e.g., celiac disease, Crohn's disease), leading to deficiencies and weight loss.

• Secondary mechanism: Metabolic imbalances - Disorders like diabetes or hyperthyroidism alter metabolic rates, causing either excessive nutrient utilization or inadequate storage, impacting nutritional status.

• Key complication: Nutrient deficiencies - Resulting from either primary or secondary mechanisms, deficiencies can lead to anemia, impaired wound healing, and increased susceptibility to infections, necessitating targeted nutritional interventions.

Patient Profile

Demographics:

42-year-old female, office manager

History:

• Key past medical history: Type 2 Diabetes, Hypertension

• Current medications: Metformin, Lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Unintentional weight loss over the past 3 months

• Key symptoms: Fatigue, decreased appetite, occasional nausea

• Vital signs: Blood pressure 145/90 mmHg, Heart rate 102 bpm, Respiratory rate 18 breaths per minute, Temperature 37.2°C, BMI 18.5

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team conducted a series of diagnostic tests to pinpoint the underlying causes of the patient's altered nutrition and weight loss. Blood tests revealed a hemoglobin level of 10.5 g/dL, indicating mild anemia, likely due to iron deficiency. Serum iron levels were notably low at 30 µg/dL, with a decreased ferritin level of 10 ng/mL, confirming the suspicion of iron deficiency anemia. Additionally, the patient's vitamin B12 and folate levels were marginally below normal, suggesting a broader spectrum of nutritional deficiencies possibly linked to malabsorption.

A comprehensive metabolic panel showed elevated liver enzymes, with ALT at 68 U/L and AST at 55 U/L, raising concerns about potential liver involvement or non-alcoholic fatty liver disease, which can be associated with her type 2 diabetes. The thyroid function tests were within normal limits, with a TSH of 2.3 µIU/mL, ruling out hyperthyroidism as a contributing factor to her weight loss. An upper endoscopy with biopsy was subsequently performed, revealing mild villous atrophy in the small intestine, consistent with celiac disease, which was confirmed by the presence of elevated tissue transglutaminase antibodies.

These findings suggest a dual challenge of managing the patient's nutritional deficiencies while addressing the underlying celiac disease. The team must strategize a comprehensive treatment plan that includes dietary modifications, such as a strict gluten-free diet, along with iron and vitamin supplementation, to stabilize her nutritional status and prevent further complications. This will require close monitoring of her blood glucose levels to avoid exacerbating her diabetes, as well as regular follow-up to assess the effectiveness of dietary interventions and biochemical parameters.

Section 2

Change in Patient Status:

Two weeks into the implementation of the gluten-free diet and initiation of iron and vitamin supplementation, the patient returned for a follow-up visit. She reported improved energy levels and a modest increase in her appetite. However, her physical examination revealed new concerns. The patient had developed mild peripheral edema, particularly in the lower extremities, and complained of occasional shortness of breath, particularly when climbing stairs. Her weight remained stable, but these new symptoms prompted further evaluation.

Vital signs indicated a blood pressure of 145/92 mmHg and a heart rate of 98 beats per minute. Her blood glucose levels, which were being closely monitored, showed occasional spikes, with a recent fasting glucose level of 160 mg/dL. A repeat comprehensive metabolic panel showed persistent elevation of liver enzymes, with ALT rising to 75 U/L and AST to 60 U/L, while albumin levels were slightly decreased at 3.3 g/dL. Given these findings, the healthcare team became concerned about the potential development of hepatic complications secondary to non-alcoholic fatty liver disease, possibly exacerbated by fluid retention and nutritional deficiencies.

To address these evolving issues, the team considered the need for additional investigations, such as imaging studies of the liver, to further evaluate the extent of hepatic involvement. They also discussed potential adjustments to her diabetes management plan to better control her blood glucose levels, while considering strategies to address the peripheral edema, possibly related to hypoalbuminemia or subtle changes in cardiac function. This situation highlights the complexity of managing intertwined conditions, requiring careful balancing of interventions to optimize the patient's overall health and prevent further complications.

Section 3

New Diagnostic Results:

Following the decision to further investigate the potential hepatic complications, an abdominal ultrasound was conducted, revealing mild hepatomegaly with increased echogenicity, suggestive of fatty infiltration consistent with non-alcoholic fatty liver disease (NAFLD). No evidence of hepatic fibrosis or cirrhosis was noted at this stage. This finding corroborated the elevated liver enzyme levels observed in the comprehensive metabolic panel and suggested that the patient's dietary and metabolic issues might be contributing to hepatic stress.

Simultaneously, the healthcare team pursued a cardiac evaluation to address the peripheral edema and occasional shortness of breath. An echocardiogram was performed, which showed a slightly reduced ejection fraction of 45%, indicating mild systolic dysfunction. This new cardiac finding could potentially explain the patient's symptoms and pointed towards early heart failure with preserved ejection fraction (HFpEF), potentially exacerbated by her nutritional deficiencies and poorly controlled glucose levels.

These diagnostic results necessitated a re-evaluation of the patient's treatment plan. The team considered initiating a low-sodium diet and prescribed diuretics to manage the fluid retention. Furthermore, they discussed the potential need for a tailored exercise program to improve cardiac function while monitoring her glucose levels closely to prevent further spikes. These adjustments aimed to address the intertwined nature of her hepatic and cardiac conditions, offering a more comprehensive approach to her care while anticipating the need for regular follow-up to monitor the effectiveness of these interventions.

Section 4

Change in Patient Status:

Several weeks into the revised treatment plan, the patient returned for a follow-up appointment, presenting with new symptoms of increased fatigue and occasional palpitations. Upon assessment, her vital signs revealed a blood pressure of 150/95 mmHg, heart rate of 92 beats per minute, and a weight increase of 2 kg since her last visit, despite adherence to the low-sodium diet and diuretic therapy. Her fasting blood glucose level was 145 mg/dL, indicating persistent hyperglycemia. The patient reported adherence to the prescribed exercise regimen but mentioned feeling more tired than usual after physical activity, which was uncharacteristic for her previous energy levels.

The healthcare team noted these changes could indicate a progression in her cardiac condition, potentially linked to the mild systolic dysfunction identified earlier. The slightly elevated blood pressure and heart rate, along with weight gain, suggested inadequate fluid management, possibly due to suboptimal diuretic dosing or poor dietary compliance. Additionally, the persistent hyperglycemia posed a continued risk for exacerbating her hepatic and cardiac issues, underscoring the need for more aggressive glycemic control.

In response to these findings, the team decided to adjust the patient's diuretic dosage to better manage her fluid balance and considered the introduction of a beta-blocker to address her heart rate and blood pressure, while also potentially benefiting her cardiac function. Furthermore, they planned to refer her to a dietitian for more personalized nutritional counseling aimed at improving her glucose control and managing her overall metabolic health. These steps intended to prevent further deterioration and stabilize her condition, reflecting a dynamic approach to her care in light of evolving clinical needs.

Section 5

After adjusting the patient's diuretic dosage and introducing a beta-blocker, the healthcare team scheduled another follow-up appointment to evaluate the response to these interventions. Upon this subsequent visit, the patient reported a noticeable reduction in palpitations and a slight improvement in her energy levels, especially after physical activity. However, she continued to express concerns about persistent fatigue and occasional dizziness.

The clinical assessment revealed a blood pressure of 140/85 mmHg and a heart rate of 76 beats per minute, indicating some improvement in cardiovascular parameters. Her weight had stabilized, showing no further gain, which suggested better fluid management. Nonetheless, her fasting blood glucose level remained elevated at 150 mg/dL, indicating that glycemic control had yet to be achieved. Additionally, the patient reported experiencing occasional numbness and tingling in her extremities, raising concerns about potential diabetic neuropathy or complications from her altered nutrition status.

Given these new findings, the healthcare team recognized the need to intensify the patient's diabetes management strategy. They considered increasing her oral hypoglycemic dose and emphasized the importance of lifestyle modifications, such as consistent carbohydrate counting and meal timing, in collaboration with the dietitian. The team also explored the possibility of incorporating a low-impact exercise program tailored to her current energy levels to mitigate fatigue while maintaining physical activity. These adjustments aimed to address the multifaceted nature of her condition and prevent further complications, setting the stage for the next phase of her treatment plan.